Markets:

Overview

News

Currencies

International

Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

262.63 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Natera, Inc. - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

August 04, 2023

Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.

Via Benzinga

Why Natera Stock Is Soaring Today ↗

August 04, 2023

This DNA testing leader passed the test in Q2.

Via The Motley Fool

Earnings Scheduled For August 3, 2023 ↗

August 03, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.

Via Benzinga

Natera Earnings Preview ↗

August 02, 2023

Via Benzinga

What 7 Analyst Ratings Have To Say About Natera ↗

July 21, 2023

Via Benzinga

Analyst Expectations for Natera's Future ↗

May 30, 2023

Via Benzinga

Investors Cheer Jobs Report: Why Are These 5 Stocks And 5 ETFs Shining On Friday? ↗

August 04, 2023

Via Benzinga

Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday ↗

August 04, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 04, 2023

Via Benzinga

The Latest Analyst Ratings for Natera ↗

March 03, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 03, 2023

Via Benzinga

Natera Reports Second Quarter 2023 Financial Results

August 03, 2023

From Natera, Inc.

Via Business Wire

Natera to Participate in Canaccord Genuity 43rd Annual Growth Conference

August 02, 2023

From Natera, Inc.

Via Business Wire

Natera Files Patent Infringement Suit Against NeoGenomics

July 31, 2023

From Natera, Inc.

Via Business Wire

Natera Announces Completion of Enrollment to the Randomized, Phase III ALTAIR Trial of Signatera™ in Colorectal Cancer

July 28, 2023

From Natera, Inc.

Via Business Wire

Natera to Report its Second Quarter 2023 Results on August 3rd

July 27, 2023

From Natera, Inc.

Via Business Wire

Court Issues Favorable Ruling for Natera in False Advertising Trial Against CareDx; Eliminates all Damages

July 17, 2023

From Natera, Inc.

Via Business Wire

Natera to Participate in Goldman Sachs 44th Annual Global Healthcare Conference

June 06, 2023

From Natera, Inc.

Via Business Wire

Natera Announces Data from the ProActive Study that Supports Prospera™ Kidney as an Early Indicator of Transplant Rejection

June 04, 2023

From Natera, Inc.

Via Business Wire

New Natera Data to be Presented at the 2023 ASCO Annual Meeting in 13 Studies Across Multiple Cancer Types

May 30, 2023

From Natera, Inc.

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

May 26, 2023

Via Benzinga

Jury Rules in Favor of Natera, Finding all Asserted Patents Valid and Infringed by ArcherDX/Invitae; Awards $19.35 Million in Past Damages for Royalties and Lost Profits

May 15, 2023

From Natera, Inc.

Via Business Wire

Natera Reports First Quarter 2023 Financial Results

May 09, 2023

From Natera, Inc.

Via Business Wire

Natera Announces New Publication from I-SPY2 Trial Reinforcing Clinical Utility of Signatera™ for Breast Cancer Patients in the Neoadjuvant Setting

May 08, 2023

From Natera, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2023 ↗

May 05, 2023

Via Benzinga

Natera Announces First Quarter 2023 Earnings Conference Call

May 02, 2023

From Natera, Inc.

Via Business Wire

Natera Announces New Signatera™ MRD Data at 2023 AACR Annual Meeting

April 14, 2023

From Natera, Inc.

Via Business Wire

New Publication Demonstrates Utility of Natera’s Signatera™ Test in Melanoma

March 22, 2023

From Natera, Inc.

Via Business Wire

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗

March 15, 2023

To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.

Via InvestorPlace

Catalent Stock Showing Improved Relative Strength Rating ↗

March 10, 2023

On Friday, Catalent stock earned a positive adjustment to its Relative Strength (RS) Rating, from 63 to 74.

Via Investor's Business Daily

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Natera, Inc. - Common Stock (NQ:NTRA)

All News about Natera, Inc. - Common Stock

Starting at /week.